Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation

Class:IdLiteratureReference:9615136
_displayNamePerindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation
_timestamp2018-07-31 09:26:58
author[Person:9615181] Chalmers, John
[Person:9615174] MacMahon, Stephen
created[InstanceEdit:9615129] Jassal, Bijay, 2018-07-31
journalJ Hypertens Suppl
pagesS9-14
pubMedIdentifier12953850
titlePerindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation
volume21
year2003
(literatureReference)[ChemicalDrug:9614952] perindoprilat [extracellular region]
[ChemicalDrug:9619006] perindopril [endoplasmic reticulum lumen]
[ChemicalDrug:9619044] perindoprilat [endoplasmic reticulum lumen]
[Summation:9614951] Angiotensin-converting enzyme (ACE) is a central component o...
[Change default viewing format]
No pathways have been reviewed or authored by Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation (9615136)